MyAverix Finance
F · Healthcare
Telix Pharmaceuticals Limited (T3X)
Biotechnology
Telix Pharmaceuticals Limited (T3X) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $2.68B, P/E ratio is 18.00, net margin is -0.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for T3X
Telix Pharmaceuticals Limited (T3X) — FAQ
What is Telix Pharmaceuticals Limited's market cap?
Telix Pharmaceuticals Limited (T3X) has a reported market cap of $2.68B (data as of 2026-03-30).
What is T3X's P/E ratio?
The price-to-earnings (P/E) ratio for Telix Pharmaceuticals Limited (T3X) is 18.00 (data as of 2026-03-30).
Does Telix Pharmaceuticals Limited pay a dividend?
Dividend yield is not available in the current snapshot for Telix Pharmaceuticals Limited (T3X). Check the MyAverix Finance app for the latest dividend data.
What sector is Telix Pharmaceuticals Limited in?
Telix Pharmaceuticals Limited (T3X) is classified in the Healthcare sector (Biotechnology industry).
What exchange is T3X listed on?
T3X is listed on F.
What is Telix Pharmaceuticals Limited's net margin?
Telix Pharmaceuticals Limited (T3X) reports a net margin of -0.9% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.